The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).

Abroad (travel likely)RecruitingPHASE4

Conditions

HER2-positive Breast Cancer · Advanced Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Contact: Study coordinator (Lina zhang) · linazh_001@163.com · 18531117825

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks

Breast Cancer · Chemotherapy Effect

Abroad (travel likely)RecruitingPHASE3

Hanzhou, China

OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk

Breast Cancer · Estrogen Receptor Positive Tumor · HER2-negative Breast Cancer

Abroad (travel likely)RecruitingPHASE4

Seoul, South Korea · Seoul, South Korea

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

Breast Neoplasms · Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Santa Monica, United States · Skokie, United States

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Breast Neoplasms · Breast Cancer · Breast Tumors

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Scottsdale, United States